Daiichi Sankyo Company, Limited (DSKYF)
USD 26.5
(0.0%)
USD 26.5
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 974.77 Billion JPY | 22.9% |
| 2023 | 793.13 Billion JPY | 32.27% |
| 2022 | 599.62 Billion JPY | 10.22% |
| 2021 | 544.04 Billion JPY | 4.51% |
| 2020 | 520.55 Billion JPY | 9.67% |
| 2019 | 474.65 Billion JPY | -5.42% |
| 2018 | 501.84 Billion JPY | 5.02% |
| 2017 | 477.87 Billion JPY | -6.99% |
| 2016 | 513.77 Billion JPY | -1.55% |
| 2015 | 521.86 Billion JPY | 3.68% |
| 2014 | 503.35 Billion JPY | -9.7% |
| 2013 | 557.43 Billion JPY | -8.63% |
| 2012 | 610.07 Billion JPY | 46.95% |
| 2011 | 415.14 Billion JPY | -2.32% |
| 2010 | 425 Billion JPY | 7.31% |
| 2009 | 396.03 Billion JPY | 8.8% |
| 2008 | 364 Billion JPY | -31.06% |
| 2007 | 527.99 Billion JPY | 10.16% |
| 2006 | 479.3 Billion JPY | 65.84% |
| 2005 | 289.01 Billion JPY | 3.54% |
| 2004 | 279.13 Billion JPY | 6.81% |
| 2003 | 261.33 Billion JPY | 5.89% |
| 2002 | 246.8 Billion JPY | 5.34% |
| 2001 | 234.29 Billion JPY | 10.39% |
| 2000 | 212.23 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 213.73 Billion JPY | -11.52% |
| 2024 FY | 995.77 Billion JPY | 25.55% |
| 2024 Q3 | 251.29 Billion JPY | 9.27% |
| 2024 Q4 | 307.16 Billion JPY | 22.23% |
| 2024 Q2 | 229.97 Billion JPY | 7.6% |
| 2023 Q4 | 241.56 Billion JPY | 14.64% |
| 2023 FY | 793.13 Billion JPY | 32.27% |
| 2023 Q3 | 210.71 Billion JPY | 11.37% |
| 2023 Q2 | 189.2 Billion JPY | 10.45% |
| 2023 Q1 | 171.3 Billion JPY | -12.53% |
| 2022 Q2 | 139.51 Billion JPY | 4.78% |
| 2022 Q1 | 133.14 Billion JPY | -20.52% |
| 2022 Q4 | 195.84 Billion JPY | 30.54% |
| 2022 FY | 599.62 Billion JPY | 10.22% |
| 2022 Q3 | 150.03 Billion JPY | 7.54% |
| 2021 Q1 | 120.61 Billion JPY | -21.99% |
| 2021 Q2 | 132.51 Billion JPY | 9.87% |
| 2021 Q3 | 139.78 Billion JPY | 5.49% |
| 2021 Q4 | 167.51 Billion JPY | 19.84% |
| 2021 FY | 544.04 Billion JPY | 4.51% |
| 2020 Q3 | 128.86 Billion JPY | 15.1% |
| 2020 Q2 | 111.95 Billion JPY | 7.3% |
| 2020 Q1 | 104.34 Billion JPY | -25.63% |
| 2020 FY | 520.55 Billion JPY | 9.67% |
| 2020 Q4 | 154.61 Billion JPY | 19.98% |
| 2019 Q4 | 140.31 Billion JPY | 18.03% |
| 2019 Q3 | 118.87 Billion JPY | 6.95% |
| 2019 Q2 | 111.14 Billion JPY | 0.07% |
| 2019 FY | 474.65 Billion JPY | -5.42% |
| 2019 Q1 | 111.07 Billion JPY | -23.67% |
| 2018 Q2 | 144.82 Billion JPY | 21.95% |
| 2018 Q4 | 145.52 Billion JPY | 12.99% |
| 2018 Q3 | 128.78 Billion JPY | -11.07% |
| 2018 FY | 501.84 Billion JPY | 5.02% |
| 2018 Q1 | 118.75 Billion JPY | -22.31% |
| 2017 Q4 | 152.86 Billion JPY | 20.86% |
| 2017 Q3 | 126.48 Billion JPY | 4.21% |
| 2017 Q2 | 121.37 Billion JPY | 4.55% |
| 2017 Q1 | 116.09 Billion JPY | -30.48% |
| 2017 FY | 477.87 Billion JPY | -6.99% |
| 2016 Q1 | 115.32 Billion JPY | 34.74% |
| 2016 Q4 | 166.98 Billion JPY | 21.37% |
| 2016 FY | 513.77 Billion JPY | -1.55% |
| 2016 Q3 | 137.58 Billion JPY | 17.09% |
| 2016 Q2 | 117.5 Billion JPY | 1.89% |
| 2015 FY | 521.86 Billion JPY | 3.68% |
| 2015 Q2 | 122.23 Billion JPY | 5.07% |
| 2015 Q3 | 134.93 Billion JPY | 10.39% |
| 2015 Q4 | 85.59 Billion JPY | -36.57% |
| 2015 Q1 | 116.32 Billion JPY | -29.06% |
| 2014 Q3 | 133.71 Billion JPY | -4.6% |
| 2014 Q1 | 149.85 Billion JPY | -7.65% |
| 2014 FY | 503.35 Billion JPY | -9.7% |
| 2014 Q4 | 163.98 Billion JPY | 22.63% |
| 2014 Q2 | 140.16 Billion JPY | -6.47% |
| 2013 Q2 | 139.82 Billion JPY | -2.53% |
| 2013 Q4 | 162.27 Billion JPY | 17.09% |
| 2013 FY | 557.43 Billion JPY | -8.63% |
| 2013 Q1 | 143.44 Billion JPY | 8878.89% |
| 2013 Q3 | 138.59 Billion JPY | -0.88% |
| 2012 FY | 610.07 Billion JPY | 46.95% |
| 2012 Q1 | 128.26 Billion JPY | 18.43% |
| 2012 Q2 | 62.21 Billion JPY | -51.5% |
| 2012 Q3 | 213.5 Billion JPY | 243.2% |
| 2012 Q4 | -1.63 Billion JPY | -100.77% |
| 2011 Q3 | 107.94 Billion JPY | 5.9% |
| 2011 FY | 415.14 Billion JPY | -2.32% |
| 2011 Q4 | 108.3 Billion JPY | 0.34% |
| 2011 Q2 | 101.92 Billion JPY | -22.38% |
| 2011 Q1 | 131.3 Billion JPY | 14.53% |
| 2010 Q2 | 107.48 Billion JPY | 5.94% |
| 2010 Q3 | 101.4 Billion JPY | -5.65% |
| 2010 Q4 | 114.65 Billion JPY | 13.06% |
| 2010 FY | 425 Billion JPY | 7.31% |
| 2010 Q1 | 101.46 Billion JPY | -10.93% |
| 2009 Q2 | 97.97 Billion JPY | 0.0% |
| 2009 Q3 | 97.85 Billion JPY | -0.12% |
| 2009 Q4 | 113.91 Billion JPY | 16.41% |
| 2009 FY | 396.03 Billion JPY | 8.8% |
| 2008 FY | 364 Billion JPY | -31.06% |
| 2007 FY | 527.99 Billion JPY | 10.16% |
| 2006 FY | 479.3 Billion JPY | 65.84% |
| 2005 FY | 289.01 Billion JPY | 3.54% |
| 2004 FY | 279.13 Billion JPY | 6.81% |
| 2003 FY | 261.33 Billion JPY | 5.89% |
| 2002 FY | 246.8 Billion JPY | 5.34% |
| 2001 FY | 234.29 Billion JPY | 10.39% |
| 2000 FY | 212.23 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AstraZeneca PLC | 29.57 Billion USD | -3195.618% |
| Bristol-Myers Squibb Company PFD CONV 2 | 17.07 Billion USD | -5610.14% |
| CSPC Pharmaceutical Group Limited | 2.14 Billion USD | -45302.671% |
| Clarus Therapeutics Holdings, Inc. | 50.96 Million USD | -1912391.907% |
| Novartis AG | 24.87 Billion USD | -3819.336% |
| PT Kalbe Farma Tbk. | 11823.24 Billion USD | 91.755% |